Step 1 of 2
Cardiology must recognize lipoprotein(a) or Lp(a) as an independent and genetically determined risk factor of atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis. Use these slides to understand the latest guidelines on assessing and managing Lp(a) in your practice, including expert-informed strategies for interpreting results, intensifying modifiable risk factor management, and guideline-directed lipid-lowering therapy for ASCVD risk reduction, as well as counseling patients and their families about cascade testing as indicated.